Plozalizumab
Modify Date: 2024-04-05 22:01:55
Plozalizumab structure
|
Common Name | Plozalizumab | ||
|---|---|---|---|---|
| CAS Number | 1610761-46-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PlozalizumabPlozalizumab (MLN-1202) is a specific humanized anti-CCR2 antibody. Plozalizumab can be used for malignant melanoma research[1]. |
| Name | Plozalizumab |
|---|
| Description | Plozalizumab (MLN-1202) is a specific humanized anti-CCR2 antibody. Plozalizumab can be used for malignant melanoma research[1]. |
|---|---|
| Related Catalog | |
| Target |
CCR2 |
| References |
| No Any Chemical & Physical Properties |